Clinical Diagnostics
Find the latest research on a wide range of molecular and serological assays currently available or under development:Detection of Virus and Its Components (including Molecular Diagnostics)
January 2021
- *NEW Development of a saliva-optimized RT-LAMP assay for SARS-CoV-2.
- *NEW Diagnostic performance and clinical implications of rapid SARS-CoV-2 antigen testing in Mexico using real-world nationwide COVID-19 registry data.
- *NEW Direct detection of SARS-CoV-2 RNA using high-contrast pH-sensitive dyes.
- IGI-LuNER: single-well multiplexed RT-qPCR test for SARS-CoV-2.
- Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy.
- A smartphone-read ultrasensitive and quantitative saliva test for COVID-19.
- *Research Tool Rapid detection of SARS-CoV-2 with Cas13.
- Reliable and accurate diagnostics from highly multiplexed sequencing assays.
- Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry.
- Rapid detection of SARS-CoV-2 with CRISPR-Cas12a.
- Variable sensitivity in molecular detection of SARS-CoV-2 in European Expert Laboratories: External Quality Assessment, June – July 2020.
December 2020
- Rapid lateral flow immunoassay for the fluorescence detection of SARS-CoV-2 RNA.
- *Research Tool A Fast and Accessible Method for the Isolation of RNA, DNA, and Protein to Facilitate the Detection of SARS-CoV-2.
- Comparison of 12 Molecular Detection Assays for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
- Evaluation of the Panbio rapid antigen test for SARS-CoV-2 in primary health care centers and test sites.
- Inference of Active Viral Replication in Cases with Sustained Positive RT-PCRs for SARS-CoV-2.
- Clinical performance of the point-of-care cobas Liat for detection of SARS-CoV-2 in 20 minutes: A multicenter study.
- Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2.
- An enhanced isothermal amplification assay for viral detection.
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
Back to Top
Serology (including Neutralization)
January 2021
- *NEW *Research Tool Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.
- *NEW Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling.
- Immunologic testing for SARS-CoV-2 infection from the antigen perspective.
- Development of a Rapid Point-Of-Care Test that Measures Neutralizing Antibodies to SARS-CoV-2.
- Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study.
December 2020
- Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies.
- A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactions.
- Development of a SERS-based lateral flow immunoassay for rapid and ultra-sensitive detection of anti-SARS-CoV-2 IgM/IgG in clinical samples.
- Antibody tests have higher sensitivity at ≥15 days after symptom onset and 99% specificity for detecting SARS-CoV-2.
- Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing.
- Performance of the COVID-19 SEROSpeed IgM/IgG Rapid Test, an immunochromatographic assay for the diagnosis of SARS-CoV-2 infection: a multicenter European study.
- A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots.
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
Back to Top